Ian C. Lawrance

Alma Street
Fremantle, WA 6059, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 12, 2026

Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort.

Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort.

Journal: Gastro hep advances

Published: April 02, 2024

Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero.

Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 28, 2023

An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis.

An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis.

Journal: Journal of Crohn's & colitis

Published: September 16, 2022

Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer.

Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer.

Journal: Nutrition and cancer

Published: April 12, 2021

Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis.

Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: September 09, 2020

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford.

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford.

Journal: World journal of gastroenterology

Published: April 04, 2020

The role of a plant-based diet in the pathogenesis, etiology and management of the inflammatory bowel diseases.

The role of a plant-based diet in the pathogenesis, etiology and management of the inflammatory bowel diseases.

Journal: Expert review of gastroenterology & hepatology

Published: February 21, 2020

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome.

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome.

Journal: Expert review of gastroenterology & hepatology

Published: October 29, 2019

Vitamin D metabolites are lower with active Crohn's disease and spontaneously recover with development of remission.

Vitamin D metabolites are lower with active Crohn's disease and spontaneously recover with development of remission.

Journal: Therapeutic advances in gastroenterology

Published: April 05, 2019

Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis.

Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis.

Journal: Scandinavian journal of gastroenterology

Published: March 26, 2019

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.

Journal: Inflammatory bowel diseases

Published: February 27, 2019

Showing 1-12 of 71

Last Updated: 09/26/2026